Maryland-based Altimmune Inc. has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal candidate.
The OHDRC Pilot Program facilitates emerging research ideas, explores new methodologies and approaches and facilitates transdisciplinary research as it relates to obesity-related health disparities.
The RADx-UP program is focused on addressing disparities in COVID-19 response in underserved and vulnerable populations.
A positive attitude and UAB’s gynecologic oncology team helped Debby Davis fight and endure life-threatening ovarian cancer.
UAB researchers led a large multiple-country study and used advanced machine learning techniques for risk prediction of neonatal deaths. The study reveals that low weight among newborn infants is associated strongly to most deaths in underdeveloped settings and suggests how[…]
Two new faculty members have joined the UAB Medicine Office of Wellness, each as a part-time effort in the Professional Development Office.
F. Shawn Galin, Ph.D., professor of Medicine in the Division of Pulmonary, Allergy and Critical Care Medicine and director of the Office of Standardized Patient Education at UAB, has been named president-elect of the Association of Standardized Patient Educators, the[…]
